Insider Transactions Reported by 21 Insiders of ALPINE IMMUNE SCIENCES, INC.

Location
Seattle, WA

There are no Buy or Sell transactions made by insiders since 24 Dec 2024

ALPINE IMMUNE SCIENCES, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Decheng Capital China Life Sciences USD Fund III, L.P. 10%+ Owner $83.9M 18 Jan 2024
Jay Venkatesan Director, 10%+ Owner $36.6M 15 Jul 2022
Alpine ImmunoSciences, L.P. 10%+ Owner $33.1M 17 Sep 2021
Decheng Capital Global Healthcare Fund (Master), LP 10%+ Owner $22.1M 09 Nov 2023
Frazier Life Sciences VIII, L.P. 10%+ Owner $18.9M 11 Feb 2022
James Paul Rickey Senior Vice President, Chief Financial Officer and Corporate Secretary $0 20 May 2024
ULRICH MARTIN FUHS Chief Accounting Officer $0 20 May 2024
James N. Topper Director $0 18 May 2024
Peter A. Thompson Director $0 18 May 2024
ORBIMED ADVISORS LLC Director $0 18 May 2024
Xiangmin Cui Director, 10%+ Owner $0 18 May 2024
STANFORD L. PENG President & Head of Research and Development $0 20 May 2024
ROBERT E. CONWAY Director $0 20 May 2024
MITCHELL GOLD Executive Chairman and CEO, Director $0 18 May 2024
Christopher Peetz Director $0 20 May 2024
REMY DURAND Chief Business Officer $0 20 May 2024
Zelanna Goldberg Chief Medical Officer 01 Jun 2021
Natasha Hernday Director 20 May 2024
Wolfgang Dummer Chief Medical Officer 02 Oct 2023
Jorn Drappa Director 20 May 2024
Andrew Seth Sandler Chief Medical Officer 05 Jan 2023

Recent Insider Transactions by Companies or Individuals for ALPINE IMMUNE SCIENCES, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.